Evidence map›Paper›PMID 17384960›Full record

ArticleLangenbeck's archives of surgery2007

Sirolimus impairs wound healing.

Michael Schäffer, Robert Schier, Markus Napirei, Stefan Michalski, Thilo Traska, Richard Viebahn

Abstract read
PubMed Publisher
In one paragraph

Article in Langenbeck's archives of surgery, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. mTORC2 deficiency in cutaneous dendritic cells potentiates CD8American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  8. [Effects of rapamycin and deferoxamin on wound healing after ischemia and hypoxia].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Impaired lower extremity wound healing secondary to sirolimus after kidney transplantation.The journal of the American College of Certified Wound Specialists · 2009
    Article
  18. Article
  19. Rapamycin affects early fracture healing in mice.British journal of pharmacology · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael SchäfferDepartment of Surgery, Chirurgische Universitätsklinik, Knappschaftskrankenhaus Bochum-Langendreer, In der Schornau 23-25, 44892 Bochum-Langendreer, Germany. michael.schaeffer@kk-bochum.de
Robert Schier
Markus Napirei
Stefan Michalski
Thilo Traska
Richard Viebahn
Universitätsklinikum Knappschaftskrankenhaus Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsClinically, the immunosuppressive drug sirolimus, used in organ transplantation, appears to impair wound healing. Little is known about the mechanisms of action. We investigated the effect of sirolimus on wound healing, and we analyzed the expression of stimulating mediators of angiogenesis (VEGF, vascular endothelial growth factor) and collagen synthesis (nitric oxide) in wounds. MATERIALS AND

methodsGroups of ten rats underwent dorsal skin incision, and polyvinyl alcohol sponges were implanted subcutaneously. Beginning at the day of wounding, rats were treated with 0.5, 2.0, or 5.0 mg sirolimus/kg/day. Animals were killed 10 days later to determine wound breaking strength and reparative collagen deposition. Expression of VEGF and nitric oxide was studied in wounds.

resultsSplenic lymphocyte proliferative activity was significantly decreased by sirolimus (p < 0.05). Sirolimus levels in wound fluid were found to be approximately two- to fivefold higher than blood levels (p < 0.01). Sirolimus (2.0 and 5.0 mg kg(-1) day(-1)) reduced wound breaking strength (p < 0.01) and wound collagen deposition (p < 0.05). This was paralleled by decreased expression of VEGF and nitric oxide in wounds.

conclusionExperimentally, our data show that sirolimus impairs wound healing, and this is reflected by diminished expression of VEGF and nitric oxide in the wound.

Indexed as

AnimalsCell ProliferationCollagenDose-Response Relationship, DrugHydroxyprolineImmunosuppressive AgentsLymphocytesModels, AnimalNitric OxideNitric Oxide Synthase Type IIRatsRats, Sprague-DawleySirolimusSkinVascular Endothelial Growth Factor AWound HealingCollagenHydroxyprolineImmunosuppressive AgentsNitric OxideNitric Oxide Synthase Type IISirolimusVascular Endothelial Growth Factor A

Identifiers

PMID17384960
OpenAlexW2049288643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.